Skip to content
Logo for MiND: the markers in neuropsychiatric disorders study


if you are interested in participating, please discuss a referral with your GP, specialist or treating healthcare professional,
or, contact us

are you ready to chat with the study team?

healthcare professionals

we are now accepting referrals for people with cognitive, psychiatric and/or neurological symptoms, and healthy controls

researchers, students, & collaborators

we would love to hear from you and we are keen to collaborate

the ultimate goal of The MiND Study is to lead to routine, clinically available tests that would improve outcomes for people with cognitive, psychiatric and/or neurological symptoms, their families, clinicians and healthcare systems

we aim to do this by exploring the ability of biomarkers such as neurofilament light chain, and other markers, to lead to accurate, timely diagnosis of neurological, neurodegenerative and neuropsychiatric disorders

The MiND Study is led by Professor Dennis Velakoulis and Dr Dhamidhu Eratne, and Neuropsychiatry, The Royal Melbourne Hospital, Australia, working with a growing list of fantastic national and international collaborators

we are welcoming referrals from healthcare professionals, for people with symptoms, and healthy controls. we also welcome people to join our community and receive updates, and to collaborate with researchers and organisations

what’s new

ADRF 2023

Our latest pre-print on plasma NfL in bvFTD and psychiatric conditions

Hello again World! We’ve been quiet here, but been working away very busily. We’re very …

Hello and welcome, Tasmania!

Hello and welcome, Tasmania! We’re so pleased and excited to announce that we’re now abl…

click here for more news

contact us

please get in touch with us if you have any questions, for updates, to join our community and receive our newsletter, or if you’re interested in collaborating.
if you’re interested in joining as a participant, click here to find out more and book a phone call!